Contact

It's the GeneMedi's summary page for Target/Biomarker Introduction of PD-1,PDCD1. The page also collects GeneMedi's different modalities and formats products for PD-1 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the PD-1 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Transmembrane Protein.

Programmed cell death protein 1 (PDCD1) is an immune-inhibitory receptor expressed in activated T cells; it is involved in the regulation of T-cell functions, including those of effector CD8+ T cells. In addition, this protein can also promote the differentiation of CD4+ T cells into T regulatory cells. PDCD1 is expressed in many types of tumors including melanomas, and has demonstrated to play a role in anti-tumor immunity. Moreover, this protein has been shown to be involved in safeguarding against autoimmunity, however, it can also contribute to the inhibition of effective anti-tumor and anti-microbial immunity. [provided by RefSeq, Aug 2020]

Target IDGM-T59631
Target NamePD-1
Gene ID5133
Gene Official NamePDCD1
Gene AliasCD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1
Protein Sub-locationTransmembrane Protein
CategoryTherapeutics Target, INN Index, Immuno-oncology Target


Pre-made PD-1-specific INN-index biosimilar (antibody&conjugates)-Pembrolizumab, Cetrelimab, Cadonilimab, Lorigerlimab, zimbirelimab, Tislelizumab, Nivolumab, Pucotenlimab, Balstilimab, Rulonilimab, Zimberelimab, Geptanolimab, Camrelizumab, Pimivalimab, Zeluvalimab, Sasanlimab, Spartalizumab, Prolgolimab, Vudalimab, Sintilimab, Toripalimab, Penpulimab, Fidasimtamab, Iparomlimab, Dostarlimab, Cemiplimab, Pidilizumab, Izuralimab, Retifanlimab, Tebotelimab, Lambrolizumab, Serplulimab, Budigalimab, Nofazinlimab, Finotonlimab, Ezabenlimab

Anti-PD-1 therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Cat No.Products Name (INN Index)INN Name Previous Name Target FormatOrder
GMP-Bios-ab-435Pre-Made Pembrolizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyPembrolizumabLambrolizumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-101Pre-Made Cetrelimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyCetrelimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-088Pre-Made Cadonilimab biosimilar, Bispecific Mixed mAb and scFv, Anti-PDCD1/PD-1;CTLA4/CTLA-4 antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibodyCadonilimabPDCD1/PD-1; CTLA4/CTLA-4Bispecific Mixed mAb and scFvINN mab
GMP-Bios-ab-679Pre-Made Lorigerlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1;CTLA4/CTLA-4 Antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibodyLorigerlimabPDCD1/PD-1;CTLA4/CTLA-4Bispecific Mixed scFv (scFv-CH2-CH3-scFv)INN mab
GMP-Bios-INN-1058Pre-Made Zimbirelimab Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyzimbirelimabPDCD1/PD-1Whole  mAbINN mab
GMP-Bios-ab-581Pre-Made Tislelizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyTislelizumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-381Pre-Made Nivolumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyNivolumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-459Pre-Made Pucotenlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyPucotenlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-044Pre-Made Balstilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyBalstilimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-692Pre-Made Rulonilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyRulonilimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-648Pre-Made Zimberelimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyZimberelimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-240Pre-Made Geptanolimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyGeptanolimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-090Pre-Made Camrelizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyCamrelizumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-442Pre-Made Pimivalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyPimivalimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-644Pre-Made Zeluvalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyZeluvalimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-508Pre-Made Sasanlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodySasanlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-531Pre-Made Spartalizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodySpartalizumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-458Pre-Made Prolgolimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyProlgolimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-631Pre-Made Vudalimab biosimilar, Bispecific Mixed mAb and scFv, Anti-CTLA4/CTLA-4;PDCD1/PD-1 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3;CD279/SLEB2/hPD-1/hPD-l/hSLE1 therapeutic antibodyVudalimabCTLA4/CTLA-4;PDCD1/PD-1Bispecific Mixed mAb and scFvINN mab
GMP-Bios-ab-523Pre-Made Sintilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodySintilimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-587Pre-Made Toripalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyToripalimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-436Pre-Made Penpulimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyPenpulimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-667Pre-Made Fidasimtamab biosimilar, Whole mAb, Anti-PDCD1/PD-1;ERBB2/HER2 Antibody: Anti-CD279/PD1/SLEB2/hSLE1;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibodyFidasimtamabPDCD1/PD-1;ERBB2/HER2Bispecific Whole mAbINN mab
GMP-Bios-ab-672Pre-Made Iparomlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyIparomlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-154Pre-Made Dostarlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyDostarlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-097Pre-Made Cemiplimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyCemiplimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-441Pre-Made Pidilizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyPidilizumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-287Pre-Made Izuralimab biosimilar, Bispecific Mixed mAb and scFv, Anti-ICOS;PDCD1/PD-1 antibody: Anti-AILIM/CD278/CVID1;CD279/SLEB2/hPD-1/hPD-l/hSLE1 therapeutic antibodyIzuralimabICOS;PDCD1/PD-1Bispecific Mixed mAb and scFvINN mab
GMP-Bios-ab-480Pre-Made Retifanlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyRetifanlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-556Pre-Made Tebotelimab biosimilar, Bispecific scFv with Crossover, Anti-PDCD1/PD-1;LAG3 Antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD223 therapeutic antibodyTebotelimabPDCD1/PD-1;LAG3Bispecific scFv with CrossoverINN mab
GMP-Bios-ab-292Pre-Made Lambrolizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyLambrolizumabpembrolizumabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-515Pre-Made Serplulimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodySerplulimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-085Pre-Made Budigalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyBudigalimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-684Pre-Made Nofazinlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyNofazinlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-215Pre-Made Finotonlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyFinotonlimabPDCD1/PD-1Whole mAbINN mab
GMP-Bios-ab-203Pre-Made Ezabenlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibodyEzabenlimabPDCD1/PD-1Whole mAbINN mab



Pre-made anti-PD-1 inhibitory monoclonal antibody(mab, blocking antibody inhibitor)-benchmark reference antibody for drug discovery and mechanism of action (MOA) research

Pre-made anti-PD-1 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-PD-1 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Cat No.Antibody NameFormatClassified by tagOrder
GM-Tg-hg-T59631-AbAnti-PD-1/PDCD1 monoclonal antibodymabBiofunctional antibody, Therapeutics Target antibodymonoclonal antibody.




GENEMEDI
6th Floor, Building No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website

Apply for
Free
Sample

Sample FOC application

×